Residual, Progressive or Recurrent Grade II or III Meningioma

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Residual, Progressive or Recurrent Grade II or III Meningioma trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingPhase 2

NCT05023018

NEO100 and High-Grade Meningioma

This multi-site, Phase 2 clinical trial is an open-label study to identify the safety, pharmacokinetics, and efficacy of a repeated dose regimen of NEO100 (peri…

United States30 participantsStarted 2022-07-01

Treatment: NEO100

Residual, Progressive or Recurrent Grade II or III Meningioma

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

NEO100 and High-Grade Meningioma

All recent trials (1 shown)

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

NEO100 and High-Grade Meningioma

All recent trials (1 shown)